Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential peginterferon alfa-2a switch therapy versus continued entecavir in chronic hepatitis B
ChiCTR-TRC-13003734Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Sep 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of peginterferon alfa-2a and entecavir in Chronic Hepatitis B (CHB) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: HBeAg seroconversion. Started Sep 2013; status: completed.
02
Drugs
peginterferon alfa-2aentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-13003734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003734.